United Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Amarin USD 201.55M 28.99M 2024-09
Ardelyx USD 77.83M 7.33M 2024-12
Baxter International USD 6.51B 311M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Insmed USD 297.53M 38.34M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
J&J USD 50.32B 1.44B 2024-12
Moderna USD 2.21B 5M 2024-12
Pfizer USD 43B 216M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



United Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.